179 related articles for article (PubMed ID: 21142607)
1. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study.
Tripathi A; Youmans E; Gibson JJ; Duffus WA
AIDS Res Hum Retroviruses; 2011 Jul; 27(7):751-8. PubMed ID: 21142607
[TBL] [Abstract][Full Text] [Related]
2. Retention in care: a challenge to survival with HIV infection.
Giordano TP; Gifford AL; White AC; Suarez-Almazor ME; Rabeneck L; Hartman C; Backus LI; Mole LA; Morgan RO
Clin Infect Dis; 2007 Jun; 44(11):1493-9. PubMed ID: 17479948
[TBL] [Abstract][Full Text] [Related]
3. Predictors of time to enter medical care after a new HIV diagnosis: a statewide population-based study.
Tripathi A; Gardner LI; Ogbuanu I; Youmans E; Stephens T; Gibson JJ; Duffus WA
AIDS Care; 2011 Nov; 23(11):1366-73. PubMed ID: 22022847
[TBL] [Abstract][Full Text] [Related]
4. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
[TBL] [Abstract][Full Text] [Related]
5. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
[TBL] [Abstract][Full Text] [Related]
6. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
Onen NF; Overton ET; Presti R; Blair C; Powderly WG; Mondy K
HIV Med; 2009 Aug; 10(7):439-46. PubMed ID: 19459993
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus.
Torian LV; Wiewel EW; Liu KL; Sackoff JE; Frieden TR
Arch Intern Med; 2008 Jun; 168(11):1181-7. PubMed ID: 18541826
[TBL] [Abstract][Full Text] [Related]
8. One year survival of HIV-infected veterans with CD4 < 100 cells/mm3: data from a veteran cohort.
Breaux K; Gadde S; Graviss EA; Rodriguez-Barradas MC
AIDS Care; 2010 Jul; 22(7):886-94. PubMed ID: 20635253
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in HIV manifestations at presentation to care and continuity of care among HIV-infected persons in Taiwan.
Ko NY; Lai YY; Liu HY; Ko WC; Chang CM; Lee NY; Chen PL; Wu CJ; Lee HC
AIDS Care; 2011 Oct; 23(10):1254-63. PubMed ID: 21939404
[TBL] [Abstract][Full Text] [Related]
10. How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia.
Blacher RJ; Muiruri P; Njobvu L; Mutsotso W; Potter D; Ong'ech J; Mwai P; Degroot A; Zulu I; Bolu O; Stringer J; Kiarie J; Weidle PJ
AIDS Care; 2010 Nov; 22(11):1323-31. PubMed ID: 20711886
[TBL] [Abstract][Full Text] [Related]
11. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
Townsend ML; Jackson GL; Smith R; Wilson KH
Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
[TBL] [Abstract][Full Text] [Related]
12. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
13. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
14. Time to first annual HIV care visit and associated factors for patients in care for HIV infection in 10 US cities.
Sullivan PS; Juhasz M; McNaghten AD; Frankel M; Bozzette S; Shapiro M
AIDS Care; 2011 Oct; 23(10):1314-20. PubMed ID: 21939408
[TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.
Bunupuradah T; Suntarattiwong P; Li A; Sirivichayakul S; Pancharoen C; Boonrak P; Puthanakit T; Kerr SJ; Ruxrungtham K; Chotpitayasunondh T; Hirschel B; Ananworanich J;
Int J Infect Dis; 2010 Apr; 14(4):e311-6. PubMed ID: 19699673
[TBL] [Abstract][Full Text] [Related]
17. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
18. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
[TBL] [Abstract][Full Text] [Related]
19. [Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].
Romeu J; Balagué M; Ruiz L; Marfil S; Puig T; Arnó A; Veny A; Tural C; Sirera G; Clotet B
Med Clin (Barc); 1998 Jun; 110(20):761-7. PubMed ID: 9666416
[TBL] [Abstract][Full Text] [Related]
20. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
